Literature DB >> 15107070

Induction of calprotectin release by Porphyromonas gingivalis lipopolysaccharide in human neutrophils.

J Kido1, R Kido, M Kataoka, M K Fagerhol, T Nagata.   

Abstract

Calprotectin, a major cytosolic protein of leukocytes, is detected in neutrophils, monocytes/macrophages, and epithelial cells. This protein is known to be a marker for several inflammatory diseases and is detected in inflammatory gingival tissue with periodontal disease. Recently, we found that the calprotectin level in gingival crevicular fluid from periodontitis patients was significantly higher than that of healthy subjects. However, the regulation of calprotectin in periodontal disease is unclear. In the present study, we investigated the effect of lipopolysaccharides of periodontopathic bacteria on calprotectin release from human neutrophils. Neutrophils from healthy donors were treated with lipopolysaccharides from Porphyromonas gingivalis (P-LPS), Actinobacillus actinomycetemcomitans, Prevotella intermedia, Fusobacterium nucleatum, and Escherichia coli. Calprotectin of neutrophil was identified by immunoblotting and calprotectin amount was determined by ELISA. Two subunits (10 and 14 kDa) of calprotectin were observed in the cell and medium fractions from neutrophils. P-LPS increased calprotectin release from seven to 16 times the control level after 30 min and its effect appeared in a dose-dependent manner (10-1000 ng/ml). Lipopolysaccharides from A. actinomycetemcomitans, P. intermedia, F. nucleatum, and E. coli also induced calprotectin release from neutrophils. These results suggest that lipopolysaccharides from periodontopathic bacteria induce calprotectin release from human neutrophils. Copyright Blackwell Munksgaard, 2004.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15107070     DOI: 10.1111/j.0902-0055.2004.00139.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  8 in total

1.  Microbiological profile and calprotectin expression in naturally occurring and experimentally induced gingivitis.

Authors:  Roberto Farina; Maria Elena Guarnelli; Elena Figuero; David Herrera; Mariano Sanz; Leonardo Trombelli
Journal:  Clin Oral Investig       Date:  2011-11-30       Impact factor: 3.573

2.  Regulation of antimicrobial peptide expression in human gingival keratinocytes by interleukin-1α.

Authors:  Yuka Hiroshima; Mika Bando; Masatoshi Kataoka; Yuji Inagaki; Mark C Herzberg; Karen F Ross; Kazuo Hosoi; Toshihiko Nagata; Jun-Ichi Kido
Journal:  Arch Oral Biol       Date:  2011-02-11       Impact factor: 2.633

Review 3.  Calprotectin and the Initiation and Progression of Head and Neck Cancer.

Authors:  P P Argyris; Z M Slama; K F Ross; A Khammanivong; M C Herzberg
Journal:  J Dent Res       Date:  2018-02-14       Impact factor: 6.116

4.  Endotoxin Exposure Increases LL-37 - but Not Calprotectin - in Healthy Human Airways.

Authors:  Margaretha E Smith; Marit Stockfelt; Sara Tengvall; Peter Bergman; Anders Lindén; Ingemar Qvarfordt
Journal:  J Innate Immun       Date:  2017-06-13       Impact factor: 7.349

5.  An inflammation loop orchestrated by S100A9 and calprotectin is critical for development of arthritis.

Authors:  Annabelle Cesaro; Nadia Anceriz; Audrey Plante; Nathalie Pagé; Mélanie R Tardif; Philippe A Tessier
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

Review 6.  Linkage of Infection to Adverse Systemic Complications: Periodontal Disease, Toll-Like Receptors, and Other Pattern Recognition Systems.

Authors:  Shannon M Wallet; Vishwajeet Puri; Frank C Gibson
Journal:  Vaccines (Basel)       Date:  2018-04-05

Review 7.  Role of Calprotectin as a Biomarker in Periodontal Disease.

Authors:  Lili Wei; Mingwen Liu; Haofei Xiong
Journal:  Mediators Inflamm       Date:  2019-08-21       Impact factor: 4.711

8.  Neutrophils exhibit an individual response to different oral bacterial biofilms.

Authors:  Carina Mikolai; Katja Branitzki-Heinemann; Alexandra Ingendoh-Tsakmakidis; Meike Stiesch; Maren von Köckritz-Blickwede; Andreas Winkel
Journal:  J Oral Microbiol       Date:  2020-12-09       Impact factor: 5.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.